Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Novo Nordisk A S's market cap was $178.60B on Nov 3, 2026, against $219.16B a year earlier. Over the last 5 years it ranged from $163.32B to $636.33B, with a median of $306.52B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 3, 2026 | $178.60B | -21.0% |
| 2025 | Dec 31, 2025 | $225.96B | -41.1% |
| 2024 | Dec 31, 2024 | $383.48B | -17.6% |
| 2023 | Dec 29, 2023 | $465.53B | +48.9% |
| 2022 | Dec 30, 2022 | $312.64B | +18.8% |
| 2021 | Dec 31, 2021 | $263.20B | +57.0% |
| 2020 | Dec 31, 2020 | $167.64B | +19.5% |
| 2019 | Dec 31, 2019 | $140.32B | +22.9% |
| 2018 | Dec 31, 2018 | $114.17B | -16.1% |
| 2017 | Dec 29, 2017 | $136.04B | +47.2% |
| 2016 | Dec 30, 2016 | $92.44B | – |
See a number that looks wrong?